Comparing the Blood Safety on the Blood Donors within the Reli-gious Ceremonies and Routine Conditions

Document Type : Original Article(s)

Authors

1 Professor, Department of Infectios Diseases, School of Medicine, Isfahan Uiversity of Medical Sciences, Isfahan, Iran

2 Medical Student, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Assistant Professor, Department of Infectios Diseases, School of Medicine, Isfahan Uiversity of Medical Sciences, Isfahan, Iran

Abstract

Background: This stydy aimed to compare the blood safety according to viral makers of hepatitis B and C and AIDS, on the blood donors within the religious ceremonies and routine conditions.Methods: In this retrospective research, 4808 blood samples of two groups of donors, routine donors and the religious ceremony donors, was evaluated for HBsAg, HIV Ab, and HCV Ab viral markers.Finding: The HBs Ag prevalence in the religious ceremony donors significantly was less than the routine conditions, but there was no statistical different in HCV Ab prevalence. Also there was not any report of positive HIV antibody and there was no significant different between the two groups of donors in summation of HIV Ab, HCV Ab and HBs Ag markers.Conclusion: The two groups of this study, routine conditions donors and religious ceremonic donors, had same conditions in safety of blood.

Keywords


  1. Abolghasrmi H, Pour Malek Rad D. Clinical usage of blood products. Tehran: Salemi Publication; 2000. p. 11.
  2. Schmunis GA, Zicker F, Pinheiro F, Brandling-Bennett D. Risk for transfusion-transmitted in-fectious diseases in Central and South America. Emerg Infect Dis 1998; 4(1): 5-11.
  3. Meeting of the task force on Surveilance for Emerging and Re- emerging infectious dis-eases; 1997 Des 6-8; Rio De Janeiro, Brazil; 1997.
  4. Busch MP, Guiltinan A, Skettino S, Cordell R, Zeger G, Kleinman S. Safety of blood dona-tions following a natural disaster. Transfusion 1991; 31(8): 719-23.
  5. Dodd RY, Orton SL, Notari EP, Stramer SL. Viral marker rates among blood donors before and after the terrorist attacks on the United States on September 11, 2001. Transfusion 2002; 42(9): 1240-1.
  6. Linden JV, Davey RJ, Burch JW. The Sep-tember 11, 2001 disaster and the New York blood supply. Transfusion 2002; 42(10): 1385-7.
  7. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol 2002; 17(10): 1092-7.
  8. Holland PV. Overview: diagnostic tests for viral infections transmitted by blood. Nucl Med Biol 1994; 21(3): 407-17.
  9. Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, et al. Trends in inci-dence and prevalence of major transfusion-transmissible viral infections in US blood do-nors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA 2000; 284(2): 229-35.
  10. Kasrain L, Torab Jahromi SA. Determine the frequency of those risk factors for HIV tests are blood donation action. Blood 2004; 1(1): 35-42.
  11. Alavian SM, Gholami B, Massarrat S. Hepatitis C risk factors in Iranian Volunteer donors: a case- Control Study. Tehran: Department of Health Publications; 2011.